4//SEC Filing
Kirchgraber Paul R 4
Accession 0001127602-22-024921
CIK 0000920148other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 5:00 PM ET
Size
8.5 KB
Accession
0001127602-22-024921
Insider Transaction Report
Form 4
Kirchgraber Paul R
CEO, Covance Drug Development
Transactions
- Tax Payment
Common Stock
2022-11-01$222.56/sh−892$198,524→ 13,030 total - Exercise/Conversion
Restricted Stock Unit
2022-11-01−2,007→ 2,897 total→ Common Stock (2,007 underlying) - Exercise/Conversion
Common Stock
2022-11-01+2,007→ 13,922 total
Footnotes (4)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]The Restricted Stock Units vested in three equal annual installments beginning on November 1, 2020 and are now fully vested.
- [F4]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Documents
Issuer
LABORATORY CORP OF AMERICA HOLDINGS
CIK 0000920148
Entity typeother
Related Parties
1- filerCIK 0001791393
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 5:00 PM ET
- Size
- 8.5 KB